Daniel Sullivan, Partner
Danny's practice focuses on banking & finance transactions, with a particular emphasis on structured finance.
AboutDanny's practice focuses on banking & finance transactions, with a particular emphasis on structured finance. He advises lenders, borrowers, issuers and investment managers on a range of transactions, including bilateral and syndicated facilities, public and private offerings of corporate and structured debt securities, securitisations and debt restructurings. He has extensive derivatives and synthetic products experience.
Danny is admitted to practise in England and Wales and is licensed as an attorney in New York.
- Acted for Caring Homes Group on a £298m care home portfolio sale & lease-back, together with a £75m development facility
- Represented a residential property developer on the restructuring of its approx. £100m bank facilities
- Represented AE Global Investment Solutions Ltd on the establishment of the Cavendish Opportunity Investments Limited €1bn Multi-Issuer Secured Note Programme, and on listed issuances under the programme currently totalling approx. €350m
Charles Russell Speechlys advises Puma Property Finance on the funding of a new 150-bed hotel development
Puma Property Finance invests to fund the development of a new 150-bed “Hampton by Hilton” hotel in Buckinghamshire.
Charles Russell Speechlys advises Acora on its investment round with Palatine Private Equity
Charles Russell Speechlys advised industry leading IT service provider, Acora, on its investment round with Palatine Private Equity LLP.
Charles Russell Speechlys advises Puma Property Finance on a £8.5m development loan to fund purpose-built student accommodation (PBSA) in Brighton
Charles Russell Speechlys advised Puma Property Finance on a £8.5 million loan to finance student accommodation in Brighton
Charles Russell Speechlys advises Kreos on growth capital investment in JenaValve Technologies, Inc.
Charles Russell Speechlys advised Kreos on its growth capital investment in a biotech company, JenaValve Technologies, Inc.